Tools & Tech : WordPress, woocommerce Project link: https://theclearcbd.com/ It’s tempting to think of cannabidiol (CBD), a non-psychoactive compound in cannabis, as an herbal panacea. After all, it’s being touted as a potential treatment for asthma, obesity, drug addiction, acne, Alzheimer’s, migraines, PTSD and insomnia, just to name a few conditions. But research into CBD’s healthful properties has largely been stifled in the United States, until recently. So, much of the evidence is either historical (“Napoleon’s troops probably used it!”), anecdotal (“My aunt swears by it!”) or based on lab studies of animals (the rat was unavailable for comment). However, times are changing. The June 2018 decision by the U.S. Food and Drug Administration to approve a cannabis-derived CBD drug called Epidiolex for treating certain forms of epilepsy is a positive sign that barriers to cannabis research could soon be a thing of the past. When you consider 30 states plus the